A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen (Q45125373)
Jump to navigation
Jump to search
scientific article published on 25 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen |
scientific article published on 25 February 2009 |
Statements
1 reference
A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen (English)
1 reference
Paul Ruff
1 reference
D A Vorobiof
1 reference
J P Jordaan
1 reference
G S Demetriou
1 reference
S D Moodley
1 reference
A L Nosworthy
1 reference
I D Werner
1 reference
J Raats
1 reference
L J Burgess
1 reference
25 February 2009
1 reference
1 reference
Identifiers
1 reference